XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Statement of Changes in Stockholders' Equity - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2020 $ 369 $ 9,083 $ 127,311,634 $ (105,563,124) $ 21,757,962
Balance (in shares) at Jun. 30, 2020 368,602 9,083,414      
Series A Preferred Stock issued for employee stock compensation     53,098   53,098
Series A Preferred Stock issued for employee stock compensation (in shares) 387        
Common stock issued for consulting and legal services rendered   $ 5 26,995   27,000
Common stock issued for consulting and legal services rendered (in shares)   5,135      
Net proceeds from issuance of common stock in connection with equity financing   $ 1,576 10,440,640   10,442,216
Net proceeds from issuance of common stock in connection with equity financing (in shares)   1,575,342      
Warrants issued to Scientific Advisory Board     1,986   1,986
Common shares issued for Directors fees   $ 2 11,248   11,250
Common shares issued for Directors fees (in shares)   2,040      
Net loss       (2,311,233) (2,311,233)
Balance at Sep. 30, 2020 $ 369 $ 10,666 137,845,601 (107,874,357) 29,982,279
Balance (in shares) at Sep. 30, 2020 368,989 10,665,931      
Balance at Jun. 30, 2021 $ 372 $ 11,515 144,284,593 (114,385,313) 29,911,167
Balance (in shares) at Jun. 30, 2021 371,490 11,515,170      
Series A Preferred Stock issued for employee stock compensation $ 10 $ 0 32,880 0 32,890
Series A Preferred Stock issued for employee stock compensation (in shares) 10,591 0      
Series A preferred stock issued for license agreement $ 100   934,988   935,088
Series A preferred stock issued forr license agreement (in shares) 100,000        
Common stock issued for consulting and legal services rendered   $ 6 26,994   27,000
Common stock issued for consulting and legal services rendered (in shares)   6,509      
Warrants issued to Scientific Advisory Board     1,352   1,352
Common shares issued for Directors fees   $ 4 14,996   15,000
Common shares issued for Directors fees (in shares)   3,524      
Net loss       (2,613,068) (2,613,068)
Balance at Sep. 30, 2021 $ 482 $ 11,525 $ 145,295,803 $ (116,998,381) $ 28,309,429
Balance (in shares) at Sep. 30, 2021 482,081 11,525,203